New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 24, 2013
11:50 EDTEXELExelixis announces availability of COMETRIQ in the U.S.
Exelixis announced the commercial availability of COMETRIQ for the treatment of patients with progressive, metastatic medullary thyroid cancer. The U.S. FDA approved COMETRIQ on November 29, 2012. COMETRIQ is being distributed exclusively through Diplomat Specialty Pharmacy in the U.S.
News For EXEL From The Last 14 Days
Check below for free stories on EXEL the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for EXEL

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use